Dr. Andrew Yang Sun, MD

Dr. Sun practices at Urology Partners of North Texas in Arlington, Texas.

Dr. Sun's NPI, 1033553409, was assigned on April 29, 2013. Dr. Sun graduated from Harvard Medical School in 2013. Dr. Sun holds Texas license S5084.

Dr. Sun's primary practice is Urology Partners of North Texas, at 5005 S Cooper St, Arlington, TX 76017 in Tarrant County. The practice phone is (866) 367-8768.

Dr. Sun's primary practice is Urology Partners of North Texas in Arlington, Texas. Dr. Sun is also affiliated with USMD Hospital at Arlington. The medical group on file is Urology Partners of North Texas. Dmand AI also links Dr. Sun to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sun practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Sun's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Sun is board certified in urology by the American Board of Urology. Dmand AI has Dr. Sun's licenses on file in 5 states: Texas, California, North Dakota, Ohio and Tennessee.

Dmand AI lists enlarged prostate, erectile dysfunction, kidney removal surgery, kidney stone disease, prostate cancer, testicular dysfunction and urinary endoscopy among the conditions Dr. Sun treats.

CMS data shows 2,627 Medicare services from Dr. Sun across 27 procedure codes in 2024, for 494 Medicare patients. Medicare paid $165,877 for them.

CMS counts 494 Medicare patients who saw Dr. Sun in 2024. The largest group is 65 to 74, with 299 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sun's median patient age at 61, with 3% women.

In 2024, Dr. Sun wrote 592 Medicare Part D claims for 212 patients. 98% of them were for generic drugs. CMS names the drug for 529 of them, across 10 drugs with 11 or more claims each, at $10,799 in total drug cost. In 2023, CMS named 327 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sun for performance year 2024, reported as part of a group. Dr. Sun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sun as offering telehealth.

Dmand AI links 14 papers to Dr. Sun, published from 2007 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Amino Acid Sequence, Ascorbic Acid and Erectile Dysfunction. Dr. Sun's most frequent co-authors are Andrew Yuanmi Sun, MD, Paurush Babbar and Qi X. Chen, MD.

CMS Open Payments shows 723 general payments to Dr. Sun from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Boston Scientific Corporation paid the most, $186,793.

Dmand AI lists 4 awards for Dr. Sun, most recently Administrative Chief Resident of Urology in 2018.

Dr. Sun graduated from Harvard Medical School in 2013. Dr. Sun is a member of American Society of Andrology, AUA, Endourological Society and Sexual Medicine Society of North America.

Dr. Sun is in network with 21 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.